Sickle Cell Disease Diagnosis Market Size, Growth & Demand by 2034

Coverage: By : Technology (Hemoglobin Electrophoresis, High-performance Liquid Chromatography (HPLC), Point-of-Care Tests, Other Tests); Age Group (Newborn Screening (12 months and below), Adult Screening (25 to 60 years), Other Age Groups (1 to 25 and above 60 years)); End User (Government Labs, Private Labs, Corporate Labs, PPP (Public-Private-Partnerships)), and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2024 | Base Year: 2025 | Forecast Period: 2026-2034
  • Status : Data Released
  • Report Code : TIPRE00016807
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
  • Last update date : April 28, 2026
Sickle Cell Disease Diagnosis Market Size, Growth & Demand by 2034
Report Date: April 28, 2026   |   Report Code: TIPRE00016807 Email: sales@theinsightpartners.com

2025 Market Size

US$ 2.38 Bn

Base year value

2034 Forecast

US$ 6.97 Bn

Projected by 2034

CAGR 2026-2034

12.68 %

Growth rate

Addressable Market

US$ 40.78 Bn

(2026-2034)

The Sickle Cell Disease Diagnosis Market size is expected to reach US$ 6.97 Billion by 2034 from US$ 2.38 Billion in 2025. The market is estimated to record a CAGR of 12.68% from 2026 to 2034.

The report is categorized by Technology (Hemoglobin Electrophoresis, High-performance Liquid Chromatography, Point-of-Care Tests) and further analyzes the market based on Age Group (Newborn Screening, Adult Screening, Other Age Groups). It also examines the market by End User (Government Labs, Private Labs, Corporate Labs, PPP).A comprehensive breakdown is provided at global, regional, and country levels for each of these key segments. The report includes market size and forecasts across all segments, presenting values in USD. It also delivers key statistics on the current market status of leading players, along with insights into prevailing market trends and emerging opportunities.

Purpose of the Report

The report Sickle Cell Disease Diagnosis Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  1. Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  2. Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  3. Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Sickle Cell Disease Diagnosis Market Segmentation

Technology

  1. Hemoglobin Electrophoresis
  2. High-performance Liquid Chromatography
  3. Point-of-Care Tests

Age Group

  1. Newborn Screening
  2. Adult Screening
  3. Other Age Groups

End User

  1. Government Labs
  2. Private Labs
  3. Corporate Labs
  4. PPP

Market Research Highlights

  • Global market for Sickle Cell Disease Diagnosis was valued at US$ 2.38 Billion in 2025
  • Annual market size is expected to reach US$ 6.97 Billion by 2034
  • Total addressable market (TAM) during 2026-2034 is projected to reach approximately US$ 40.78 Billion
  • Market is anticipated to register a CAGR of 12.68% during the forecast period
  • The United States represents a key market, supported by Early Screening Initiatives Boost Sickle Cell Awareness and Care, Innovative Genetic Testing Enhances Accurate Sickle Cell Diagnosis, Community Outreach Programs Empower Families in Sickle Cell Management, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Revolutionizing Sickle Cell Diagnosis with AI-Powered Solutions, Affordable Genetic Testing Kits for Early Sickle Cell Detection, Community Awareness Programs to Boost Sickle Cell Screening Rates are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including STRECK, BIOMEDOMICS INC., Hemex Health, Silver Lake Research Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, HALCYON BIOMEDICAL INCORPORATED, PerkinElmer Inc., Bio-Rad Laboratories, Inc., Daktari Diagnostics., while analyzing competitive strategies and innovation developments
  • Source: The Insight Partners' analysis based on proprietary research, government publications, company annual reports, investor presentations, industry databases, and expert interviews.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • ● Segmentations
  • ● Geography
  • ● Competitive Analysis
  • ● Language Preferences

Sickle Cell Disease Diagnosis Market: Strategic Insights

sickle-cell-disease-diagnosis-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Sickle Cell Disease Diagnosis Market Growth Drivers

  1. Early Screening Initiatives Boost Sickle Cell Awareness and Care
  2. Innovative Genetic Testing Enhances Accurate Sickle Cell Diagnosis
  3. Community Outreach Programs Empower Families in Sickle Cell Management

Sickle Cell Disease Diagnosis Market Future Trends

  1. AI-Powered Tools Revolutionize Sickle Cell Disease Diagnosis
  2. Telehealth Expands Access to Sickle Cell Care Globally
  3. Genetic Testing Advances Personalize Sickle Cell Treatment Options

Sickle Cell Disease Diagnosis Market Opportunities

  1. Revolutionizing Sickle Cell Diagnosis with AI-Powered Solutions
  2. Affordable Genetic Testing Kits for Early Sickle Cell Detection
  3. Community Awareness Programs to Boost Sickle Cell Screening Rates

Sickle Cell Disease Diagnosis Market Report Scope

Report Attribute Details
Market size in 2025 US$ 2.38 Billion
Market Size by 2034 US$ 6.97 Billion
Global CAGR (2026 - 2034) 12.68%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Technology
  • Hemoglobin Electrophoresis
  • High-performance Liquid Chromatography
  • Point-of-Care Tests
By Age Group
  • Newborn Screening
  • Adult Screening
  • Other Age Groups
By End User
  • Government Labs
  • Private Labs
  • Corporate Labs
  • PPP
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • STRECK
  • BIOMEDOMICS INC.
  • Hemex Health
  • Silver Lake Research Corporation
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Incorporated
  • HALCYON BIOMEDICAL INCORPORATED
  • PerkinElmer Inc.
  • Bio-Rad Laboratories, Inc.
  • Daktari Diagnostics.

Sickle Cell Disease Diagnosis Market Players Density: Understanding Its Impact on Business Dynamics

The Sickle Cell Disease Diagnosis Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

sickle-cell-disease-diagnosis-market-cagr

Key Selling Points

  1. Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Sickle Cell Disease Diagnosis Market, providing a holistic landscape.
  2. Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  3. Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  4. Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Sickle Cell Disease Diagnosis Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.

Trupti Wadekar
Assistant Manager,
Market Research & Consulting

Trupti is a senior consultant with over 10 years of experience in the Healthcare sector, specializing in pharmaceuticals, biotechnology, and life-sciences markets. She holds a Bachelor’s degree in Biotechnology and an MBA with dual specialization in Marketing and Pharmaceuticals & Biotechnology, combining a strong scientific foundation with a strategic and commercial perspective. Her professional experience encompasses market research, competitive intelligence, strategic advisory, and business development, supporting clients across diverse and evolving healthcare markets.

She has worked extensively on market sizing and assessment, growth strategy, market expansion, and strategic decision-making initiatives, helping clients identify opportunities and address complex business challenges. Trupti brings strong expertise in client engagement, stakeholder management, team leadership, and translating research findings into actionable business insights. Her ability to connect scientific understanding with market dynamics and commercial strategy enables her to deliver practical, high-impact solutions aligned with client objectives.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA